Finally, the study focused exclusively on three selected SNPs in the SIRT1 promoter region and did not account for other potentially relevant polymorphisms or gene–gene and gene–environment interactions that could modulate CRC risk. The gene discussed is SIRT1; the disease is colorectal carcinoma.